G. Herrera

发表

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.

Steve A Castillo, E. Dejesus, J. Gerstoft, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-Term Results of Initial Therapy With Abacavir and Lamivudine Combined With Efavirenz, Amprenavir/Ritonavir, or Stavudine

J. Bartlett, D. Irlbeck, N. Sosa, 2006, Journal of acquired immune deficiency syndromes.

Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment‐naïve, HIV‐1‐infected patients at 48 weeks

B. Clotet, A. Antinori, C. Hicks, 2013, HIV medicine.

Neurologic and psychiatric safety profile of TMC278 compared with efavirenz in treatment-naïve, HIV-1-infected patients: pooled analysis from the randomized, double-blind, Phase III ECHO and THRIVE trials at 48 weeks

B. Clotet, A. Antinori, C. Hicks, 2011 .

Availability of HIV care in Central America.

R. Cedillos, Néstor Sosa, E. Arathoon, 2001, JAMA.